Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Pediatrics/Neonatology | Genetic Disease

Phenylketonuria Clinical Trials


A listing of Phenylketonuria medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

California

Los Angeles :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Orange :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Palo Alto :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

San Diego :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

San Francisco :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Colorado

Aurora : The Children's Hospital

A Study to Evaluate Subcutaneously Administered rAvPAL-PEG in Patients With Phenylketonuria for 24 Weeks

Aurora :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

District of Columbia

Washington :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Florida

Gainesville : University of Florida

A Study to Evaluate Subcutaneously Administered rAvPAL-PEG in Patients With Phenylketonuria for 24 Weeks

Gainesville :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Jacksonville :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Miami :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Tampa :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Georgia

Decatur :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Illinois

Chicago :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Indiana

Indianapolis :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Iowa

Iowa City :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Kansas

Wichita :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Kentucky

Louisville :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Louisiana

New Orleans :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Massachusetts

Boston : Children's Hospital Boston

A Study to Evaluate Subcutaneously Administered rAvPAL-PEG in Patients With Phenylketonuria for 24 Weeks

Boston :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Minnesota

Minneapolis :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Missouri

Columbia :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Kansas City :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

St. Louis :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Nebraska

Omaha : Nebraska Medical Center

A Study to Evaluate Subcutaneously Administered rAvPAL-PEG in Patients With Phenylketonuria for 24 Weeks

Omaha :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

New York

Albany : Albany Medical College

A Study to Evaluate Subcutaneously Administered rAvPAL-PEG in Patients With Phenylketonuria for 24 Weeks

Albany :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Manhasset :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

New York :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Rochester :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

View More »

Valhalla :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

North Carolina

Chapel Hill :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Ohio

Akron :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Cincinnati :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Cleveland :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Columbus :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Oregon

Portland :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Pennsylvania

Hershey :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Philadelphia :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Pittsburgh :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Rhode Island

Providence :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

South Dakota

Sioux Falls :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Tennessee

Knoxville :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Texas

Houston :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Utah

Salt Lake City : University Utah

A Study to Evaluate Subcutaneously Administered rAvPAL-PEG in Patients With Phenylketonuria for 24 Weeks

Salt Lake City :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Virginia

Charlottesville :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Norfolk :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Wisconsin

Madison :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Milwaukee :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Germany

Darmstadt : Please contact Merck KGaA Communication Center located in

Phase 3 Open-label Study to Evaluate the Response and Safety of Kuvan® in Patients With Phenylketonuria

Puerto Rico

San Juan :

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry